Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02808832 · ClinicalTrials.gov registry record · NA
An HPV Vaccine Provider Intervention in Safety Net Clinics
A NA study, sponsored by Meharry Medical College.
- Completed
- Registry status
- NA
- Development phase
- 806
- Enrollment target
NCT02808832 is a NA study that has completed, run by Meharry Medical College. The registered enrollment target is 806 participants.
The verdict
NCT02808832, a NA study, has completed, sponsored by Meharry Medical College.
- COMPLETED
- Registry status
- NA
- Development phase
- 806 participants
- Enrollment target
Study Summary
The purpose of this study is to develop, deliver and evaluate a provider intervention for mothers and their children to encourage receipt of the human papillomavirus (HPV) vaccine in the children and appropriate cervical cancer screening in the mothers.
Interventions
- BEHAVIORAL Educational materials
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 806 participants |
| Start Date | 2010-09 |
| Est. Completion | 2016-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02808832
The ClinicalTrials.gov registry entry for NCT02808832 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 806 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Meharry Medical College, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Educational materials is the first listed.
NCT02808832 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02808832 about?
NCT02808832 is a clinical study titled "An HPV Vaccine Provider Intervention in Safety Net Clinics". The purpose of this study is to develop, deliver and evaluate a provider intervention for mothers and their children to encourage receipt of the human papillomavirus (HPV) vaccine in the children and appropriate cervical cancer screening in the mothers.
What is the current status of trial NCT02808832?
This trial is currently completed. It is a NA study. The enrollment target is 806 participants. The study started on 2010-09. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02808832?
The interventions under investigation include: Educational materials (BEHAVIORAL).
Who is sponsoring clinical trial NCT02808832?
This trial is sponsored by Meharry Medical College, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.